世界のトラディショナル血糖測定器市場:医療機器パイプライン分析2016

◆英語タイトル:Traditional Glucose Meters - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0215EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年8月1日
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、トラディショナル血糖測定器のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・トラディショナル血糖測定器の概要
・トラディショナル血糖測定器の開発動向:開発段階別分析
・トラディショナル血糖測定器の開発動向:セグメント別分析
・トラディショナル血糖測定器の開発動向:領域別分析
・トラディショナル血糖測定器の開発動向:規制Path別分析
・トラディショナル血糖測定器の開発動向:承認日(推定)別分析
・企業別トラディショナル血糖測定器の開発動向(パイプライン製品、進行中の治験)
・トラディショナル血糖測定器の最近動向
【レポートの概要】

Traditional Glucose Meters – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Traditional Glucose Meters – Medical Devices Pipeline Assessment, 2016″ provides an overview of Traditional Glucose Meters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Traditional Glucose Meters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Traditional Glucose Meters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Traditional Glucose Meters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Traditional Glucose Meters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Traditional Glucose Meters Overview 8
3 Products under Development 9
3.1 Traditional Glucose Meters – Pipeline Products by Stage of Development 9
3.2 Traditional Glucose Meters – Pipeline Products by Territory 10
3.3 Traditional Glucose Meters – Pipeline Products by Regulatory Path 12
3.4 Traditional Glucose Meters – Pipeline Products by Estimated Approval Date 13
3.5 Traditional Glucose Meters – Ongoing Clinical Trials 14
4 Traditional Glucose Meters – Pipeline Products under Development by Companies 15
4.1 Traditional Glucose Meters Companies – Pipeline Products by Stage of Development 15
4.2 Traditional Glucose Meters – Pipeline Products by Stage of Development 17
5 Traditional Glucose Meters Companies and Product Overview 18
5.1 4a Medicom GmbH Company Overview 18
5.1.1 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Ascensia Diabetes Care Holdings AG Company Overview 19
5.2.1 Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Biopeak Corporation Company Overview 20
5.3.1 Biopeak Corporation Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 BlueVine Graphene Industries, Inc. Company Overview 21
5.4.1 BlueVine Graphene Industries, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Elte Sensoric GmbH Company Overview 22
5.5.1 Elte Sensoric GmbH Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 Glucosat Company Overview 24
5.6.1 Glucosat Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 GlucoStats System Pte Ltd. Company Overview 25
5.7.1 GlucoStats System Pte Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 Grove Instruments Inc. (Inactive) Company Overview 26
5.8.1 Grove Instruments Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 IntelliDx Inc Company Overview 28
5.9.1 IntelliDx Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.10 LabStyle Innovations Corp. Company Overview 30
5.10.1 LabStyle Innovations Corp. Pipeline Products & Ongoing Clinical Trials Overview 30
5.11 LifeScan, Inc. Company Overview 32
5.11.1 LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.12 LighTouch Medical, Inc. Company Overview 33
5.12.1 LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.13 Massachusetts Institute of Technology Company Overview 36
5.13.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 36
5.14 NIR Diagnostics Inc. (Inactive) Company Overview 38
5.14.1 NIR Diagnostics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38
5.15 OrSense Ltd. Company Overview 39
5.15.1 OrSense Ltd. Pipeline Products & Ongoing Clinical Trials Overview 39
5.16 Pepex Biomedical, Inc. Company Overview 40
5.16.1 Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.17 RSP Systems A/S Company Overview 41
5.17.1 RSP Systems A/S Pipeline Products & Ongoing Clinical Trials Overview 41
5.18 Sensys Medical, Inc. Company Overview 42
5.18.1 Sensys Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.19 Sentec Pte Ltd Company Overview 43
5.19.1 Sentec Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
5.20 Socrates Health Solutions, Inc. Company Overview 44
5.20.1 Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
5.21 Spire Corporation Company Overview 45
5.21.1 Spire Corporation Pipeline Products & Ongoing Clinical Trials Overview 45
5.22 TecMed, Inc. Company Overview 47
5.22.1 TecMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.23 University of Central Florida Company Overview 49
5.23.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 49
5.24 University of Florida Company Overview 50
5.24.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 50
5.25 Worcester Polytechnic Institute Company Overview 51
5.25.1 Worcester Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 51
6 Traditional Glucose Meters- Recent Developments 52
6.1 Jul 12, 2016: PositiveID Announces Highlights for First Half of 2016 52
6.2 Jul 11, 2016: LabStyle Innovations Joins College Diabetes Network (CDN) 52
6.3 Jul 08, 2016: RSP Systems Raises USD5 Million in Series A Financing 53
6.4 Jun 21, 2016: PositiveID’s Mobile Lab Business Completed 80 Projects in the First Half of 2016 53
6.5 May 31, 2016: PositiveID Adds Benedikt von Braunmuhl to its Board of Advisors 53
6.6 May 26, 2016: PositiveID to Present at the 2016 Marcum MicroCap Conference on June 1st 54
6.7 May 17, 2016: PositiveID Reports Q1 2016 Revenue of $1.7 Million, Up from $0.1M in Q1 2015 54
6.8 May 11, 2016: LabStyle Innovations Reports Q1 2016 Results 55
6.9 May 05, 2016: LabStyle Innovations Granted Key Patent in Europe Relating to the Dario Diabetes Management Tool 56
6.10 Apr 26, 2016: Intuity Medical Receives FDA Clearance to Market POGO Automatic Blood Glucose Monitoring System 56
6.11 Mar 15, 2016: LabStyle Innovations’ Dario Blood Glucose Monitoring System online e-store and membership program live in USA 57
6.12 Mar 09, 2016: LabStyle Innovations Granted U.S. Patent Expanding IP for Fluids Testing into Industrial Applications via Mobile Devices and Apps 58
6.13 Jan 26, 2016: LabStyle Innovations to Launch Dario Blood Glucose Monitoring System in the U.S. in Q1 2016 59
6.14 Dec 22, 2015: LabStyle Innovations Receives U.S. FDA Marketing Clearance for the Dario Blood Glucose Monitoring System 59
6.15 Dec 16, 2015: Dario Diabetes Management Solution Garners Global Media Coverage 60
6.16 Dec 01, 2015: Sysmex Establishes New Subsidiary in Ghana – Reinforcing the Company’s Business Foundation in the Markets of West and Central Africa 60
6.17 Nov 11, 2015: LabStyle Innovations Enters into Distribution Agreement with Centaur Pharma 61
6.18 Oct 29, 2015: LabStyle Innovations Reports Dario Blood Glucose Monitor Demonstrates Over 99% Accuracy in New Study 61
6.19 Oct 23, 2015: Studies Presented at Diabetes Technology Meeting Demonstrate the Accuracy of ARKRAY Blood Glucose Meters and Test Strips 61
6.20 Oct 15, 2015: LabStyle Innovations to Report New Data at Diabetes Technology Meeting On October 22 and 23, 2015. 62
6.21 Oct 12, 2015: LabStyle Innovations to Present New Case Study at 5th EAI International Conference on Wireless Mobile Communication and Healthcare in London on October 15, 2015 62
6.22 Sep 30, 2015: LabStyle Innovations to Present at Health 2.0′s 9th Annual Fall Conference in Silicon Valley on October 7, 2015 63
6.23 Sep 15, 2015: Sysmex to Expand U.S. Reagent Factory – Aiming to Meet Growing Demand in the Americas 63
6.24 Sep 09, 2015: LabStyle Innovations Receives Granted Patent in the U.S. Expanding its IP to Address Management of Chronic Diseases Through Smart Phones 63
6.25 Aug 25, 2015: LabStyle Innovations to Exhibit at Australian Diabetes Society’s Annual Meeting on August 26 – 28, 2015 64
7 Appendix 65
7.1 Methodology 65
7.2 About GlobalData 67
7.3 Contact Us 67
7.4 Disclaimer 68

1.1 List of Tables
Table 1: Traditional Glucose Meters - Pipeline Products by Stage of Development 9
Table 2: Traditional Glucose Meters - Pipeline Products by Territory 11
Table 3: Traditional Glucose Meters - Pipeline Products by Regulatory Path 12
Table 4: Traditional Glucose Meters - Pipeline Products by Estimated Approval Date 13
Table 5: Traditional Glucose Meters - Ongoing Clinical Trials 14
Table 6: Traditional Glucose Meters Companies - Pipeline Products by Stage of Development 15
Table 7: Traditional Glucose Meters - Pipeline Products by Stage of Development 17
Table 8: 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview 18
Table 9: GlucoPEARL - Product Status 18
Table 10: GlucoPEARL - Product Description 18
Table 11: Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview 19
Table 12: Next Generation Blood Glucose Monitoring System - Product Status 19
Table 13: Next Generation Blood Glucose Monitoring System - Product Description 19
Table 14: Biopeak Corporation Pipeline Products & Ongoing Clinical Trials Overview 20
Table 15: Non-Invasive Glucose Analyzer - Product Status 20
Table 16: Non-Invasive Glucose Analyzer - Product Description 20
Table 17: BlueVine Graphene Industries, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 18: Minimally Invasive Glucose Monitoring Device - Product Status 21
Table 19: Minimally Invasive Glucose Monitoring Device - Product Description 21
Table 20: Elte Sensoric GmbH Pipeline Products & Ongoing Clinical Trials Overview 22
Table 21: Infrared Laser Glucometer - Product Status 22
Table 22: Infrared Laser Glucometer - Product Description 22
Table 23: Portable Infrared Laser Glucometer - Product Status 23
Table 24: Portable Infrared Laser Glucometer - Product Description 23
Table 25: Glucosat Pipeline Products & Ongoing Clinical Trials Overview 24
Table 26: Glucosat - Product Status 24
Table 27: Glucosat - Product Description 24
Table 28: GlucoStats System Pte Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25
Table 29: First Generation Glucose Monitoring Device - Product Status 25
Table 30: First Generation Glucose Monitoring Device - Product Description 25
Table 31: Grove Instruments Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 26
Table 32: Grove Glucometer - Product Status 26
Table 33: Grove Glucometer - Product Description 26
Table 34: Non-Invasive Diabetes And Pre-Diabetes Screener - Product Status 27
Table 35: Non-Invasive Diabetes And Pre-Diabetes Screener - Product Description 27
Table 36: IntelliDx Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 37: Optimus - Product Status 28
Table 38: Optimus - Product Description 29
Table 39: LabStyle Innovations Corp. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 40: Dario - Product Status 30
Table 41: Dario - Product Description 31
Table 42: Next Generation Dario Blood Glucose Monitoring Device - Product Status 31
Table 43: Next Generation Dario Blood Glucose Monitoring Device - Product Description 31
Table 44: LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 45: OneTouch Verio Blood Glucose System - Version 3 - Product Status 32
Table 46: OneTouch Verio Blood Glucose System - Version 3 - Product Description 32
Table 47: LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
Table 48: LighTouch Glucose Monitor - Product Status 33
Table 49: LighTouch Glucose Monitor - Product Description 33
Table 50: LighTouch Medical, Inc. - Ongoing Clinical Trials Overview 34
Table 51: LighTouch Glucose Monitor - In Vivo Raman Spectroscopy (IVRS) of Human Fingertip Capillary Beds 35
Table 52: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 36
Table 53: Non-Invasive Blood Glucose Monitor - Product Status 36
Table 54: Non-Invasive Blood Glucose Monitor - Product Description 37
Table 55: NIR Diagnostics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38
Table 56: GlucoNIR - Product Status 38
Table 57: GlucoNIR - Product Description 38
Table 58: OrSense Ltd. Pipeline Products & Ongoing Clinical Trials Overview 39
Table 59: Second Generation Monitor - Product Status 39
Table 60: Second Generation Monitor - Product Description 39
Table 61: Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 62: Trio Total Glucose Meter - Product Status 40
Table 63: Trio Total Glucose Meter - Product Description 40
Table 64: RSP Systems A/S Pipeline Products & Ongoing Clinical Trials Overview 41
Table 65: 3rd Generation GlucoBeam - Product Status 41
Table 66: 3rd Generation GlucoBeam - Product Description 41
Table 67: Sensys Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
Table 68: Sensys GTS - Product Status 42
Table 69: Sensys GTS - Product Description 42
Table 70: Sentec Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
Table 71: NoStrip Blood Glucose Meter - Product Status 43
Table 72: NoStrip Blood Glucose Meter - Product Description 43
Table 73: Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
Table 74: Socrates Companion - Product Status 44
Table 75: Socrates Companion - Product Description 44
Table 76: Spire Corporation Pipeline Products & Ongoing Clinical Trials Overview 45
Table 77: Non-Invasive Glucose Monitor - Product Status 45
Table 78: Non-Invasive Glucose Monitor - Product Description 46
Table 79: TecMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
Table 80: GlucoCheck Critical Care Monitor - Product Status 47
Table 81: GlucoCheck Critical Care Monitor - Product Description 47
Table 82: Surgical Suite Unit - Product Status 48
Table 83: Surgical Suite Unit - Product Description 48
Table 84: University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 49
Table 85: Non-Invasive Glucose Monitoring System - Product Status 49
Table 86: Non-Invasive Glucose Monitoring System - Product Description 49
Table 87: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 50
Table 88: Diabetic UF Sensor - Product Status 50
Table 89: Diabetic UF Sensor - Product Description 50
Table 90: Worcester Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 51
Table 91: Non-invasive Glucose Measuring Device - Product Status 51
Table 92: Non-invasive Glucose Measuring Device - Product Description 51
Table 93: Glossary 66

1.2 List of Figures
Figure 1: Traditional Glucose Meters - Pipeline Products by Stage of Development 9
Figure 2: Traditional Glucose Meters - Pipeline Products by Territory 10
Figure 3: Traditional Glucose Meters - Pipeline Products by Regulatory Path 12
Figure 4: Traditional Glucose Meters - Pipeline Products by Estimated Approval Date 13
Figure 5: Traditional Glucose Meters - Ongoing Clinical Trials 14

【掲載企業】

4a Medicom GmbH
Ascensia Diabetes Care Holdings AG
Biopeak Corporation
BlueVine Graphene Industries, Inc.
Elte Sensoric GmbH
Glucosat
GlucoStats System Pte Ltd.
Grove Instruments Inc.
IntelliDx Inc
LabStyle Innovations Corp.
LifeScan, Inc.
LighTouch Medical, Inc.
Massachusetts Institute of Technology
NIR Diagnostics Inc.
OrSense Ltd.
Pepex Biomedical, Inc.
RSP Systems A/S
Sensys Medical, Inc.
Sentec Pte Ltd
Socrates Health Solutions, Inc.
Spire Corporation
TecMed, Inc.
University of Central Florida
University of Florida
Worcester Polytechnic Institute

【レポートのキーワード】

トラディショナル血糖測定器

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[世界のトラディショナル血糖測定器市場:医療機器パイプライン分析2016]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月04日現在 219,162 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆